Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Orciprenaline |
EINECS | 209-569-1 |
CAS No. | 586-06-1 | Density | 1.199g/cm3 |
PSA | 72.72000 | LogP | 1.52010 |
Solubility | N/A | Melting Point |
100° |
Formula | C11H17 N O3 | Boiling Point | 417.5°Cat760mmHg |
Molecular Weight | 211.261 | Flash Point | 179.7°C |
Transport Information | N/A | Appearance | N/A |
Safety | Poison by ingestion, intraperitoneal and intravenous routes. Moderately toxic by subcutaneous route. Human reproductive effects by ingestion: changes in the uterus, cervix and vagina. When heated to decomposition it emits toxic fumes of NOx. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
Benzylalcohol, 3,5-dihydroxy-a-[(isopropylamino)methyl]- (6CI,8CI); (?à)-Metaproterenol; (?à)-Orciprenaline;1-(3,5-Dihydroxyphenyl)-2-(isopropylamino)ethanol; 3,5-Dihydroxy-a-[(isopropylamino)methyl]benzylalcohol; Metaproterenol; Orciprenaline |
Article Data | 6 |
MF: C11H17NO3
MW: 497.11
EINECS: 223-375-4
Density: 1.199 g/cm3
Flash Point: 179.7 °C
Index of Refraction: 1.579
Enthalpy of Vaporization: 70.73 kJ/mol
Boiling Point: 417.5 °C at 760 mmHg
Vapour Pressure: 1.02E-07 mmHg at 25°C
IUPAC Name: 5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol
Synonyms: 5-(1-Hydroxy-2-propan-2-ylamino-ethyl)benzene-1,3-diol ; 5-[1-Hydroxy-2-(1-methylethylamino)ethyl]benzene-1,3-diol
Following is the molecular structure of Orciprenaline (CAS NO.586-06-1):
Orciprenaline (CAS NO.586-06-1) is used as Bronchodilators.
Orciprenaline (CAS NO.586-06-1) Production methods: 3,5 - 2-acetic acid-based reaction of acetyl first with bromine and then reactes with isopropylamine muddle along - (3,5 - dihydroxyphenyl) -2 - isopropylamine B-one, be soluble in methanol, at room temperature with nickel catalyst hydrogenation, was iso Chuanning.
1. | orl-man TDLo:286 µg/kg | AJMSA9 American Journal of the Medical Sciences. 291 (1986),168. | ||
2. | orl-rat LD50:3370 mg/kg | TXAPA9 Toxicology and Applied Pharmacology. 8 (1966),353. | ||
3. | ivn-rat LD50:67,200 µg/kg | TXAPA9 Toxicology and Applied Pharmacology. 8 (1966),353. | ||
4. | ipr-mus LDLo:240 mg/kg | APTOA6 Acta Pharmacologica et Toxicologica. 31 (1972),33. | ||
5. | scu-mus LD50:406 mg/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 26 (1976),1404. | ||
6. | ivn-mus LD50:86 mg/kg | APTOA6 Acta Pharmacologica et Toxicologica. 38 (1976),474. | ||
7. | orl-dog LD50:125 mg/kg | TXAPA9 Toxicology and Applied Pharmacology. 8 (1966),353. | ||
8. | ivn-dog LD50:30 mg/kg | TXAPA9 Toxicology and Applied Pharmacology. 8 (1966),353. | ||
9. | orl-rbt LD50:3110 mg/kg | TXAPA9 Toxicology and Applied Pharmacology. 8 (1966),353. | ||
10. | ivn-rbt LD50:81,300 µg/kg | TXAPA9 Toxicology and Applied Pharmacology. 8 (1966),353. |
Poison by ingestion, intraperitoneal and intravenous routes. Moderately toxic by subcutaneous route. Human reproductive effects by ingestion: changes in the uterus, cervix and vagina. When heated to decomposition it emits toxic fumes of NOx.